Nemolizumab Rapidly Improves EASI, SCORAD Scores for Atopic Dermatitis; A post hoc analysis shows the investigative drug significantly improved atopic dermatitis symptoms versus placebo as soon as the first week into a phase 2 trial.

Media coverage

• Title	Nemolizumab Rapidly Improves EASI, SCORAD Scores for Atopic Dermatitis; A post hoc analysis shows the investigative drug significantly improved atopic dermatitis symptoms versus placebo as soon as the first week into a phase 2 trial.
  Media name/outlet	Consultant Live
  Country/Territory	United States
  Date	23/06/23
  URL	ct.moreover.com/?a=51212211098&p=1gw&v=1&x=1i5Y6sQYmyUktxnbUNgZ7w
  Persons	Peter Lio